山东大学学报 (医学版) ›› 2025, Vol. 63 ›› Issue (1): 1-9.doi: 10.6040/j.issn.1671-7554.0.2025.0036
• 乳腺癌多学科诊疗与临床创新—述评 • 下一篇
余之刚,郑超
YU Zhigang, ZHENG Chao
摘要: 多学科诊疗(multidisciplinary treatment, MDT)模式已成为当前优化乳腺癌诊疗的重要策略。本述评从山东省乳腺癌诊疗的现状出发,全面分析优化MDT乳腺癌诊疗的实施情况及面临的主要挑战,包括亚专业不完善、数据共享能力不足、资源配置不均以及医务人员积极性和患者参与度较低的困境。通过梳理山东省乳腺癌诊疗MDT模式本地化实践中的经验,提出一系列适合国情的创新模式,包括规范化诊疗流程、构建高效的信息共享平台、强化患者随访与支持系统以及深化专科联盟和区域合作网络。并进一步结合乳腺癌分子生物学、影像组学和人工智能等领域的最新研究,探讨多学科协作与现代技术在乳腺癌诊疗中的应用前景,指出数字医疗转型和精准医学对个体化治疗的推动作用,旨在为国内的乳腺癌诊疗工作提供理论支持和实践借鉴。
中图分类号:
| [1] 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报(医学版), 2025, 63(1): 10-16. Multidisciplinary Joint Committee on Breast Disease of Shandong Provincial Medical Association. Shandong Province expert consensus on multidisciplinary treatment of breast cancer(2024 edition)[J]. Journal of Shandong University(Health Sciences), 2025, 63(1): 10-16. [2] Emerson MA, Reeder-Hayes KE, Tipaldos HJ, et al. Integrating biology and access to care in addressing breast cancer disparities: 25 years research experience in the Carolina Breast Cancer Study[J]. Curr Breast Cancer Rep, 2020, 12(3): 149-160. [3] Blackwood O, Deb R. Multidisciplinary team approach in breast cancer care: benefits and challenges[J]. Indian J Pathol Microbiol, 2020, 63(Supplement): S105-S112. [4] Hadikadic'-Guc'i L, Ceric' T, Marijanovic' I, et al. Guidelines for breast cancer management in Bosnia and Herzegovina[J]. Biomol Biomed, 2023, 23(1): 2-14. [5] Meduri B, De Rose F, Cabula C, et al. Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group[J]. Med Oncol, 2021, 38(6): 67. doi:10.1007/s12032-021-01514-w. [6] Fabi A, Rossi A, Mocini E, et al. An integrated care approach to improve well-being in breast cancer patients[J]. Curr Oncol Rep, 2024, 26(4): 346-358. [7] Rodríguez-Reinado C, Delgado-Parrilla A, Alguacil J. Breast cancer treatment in integrated care process in Andalusia: the challenge of multidisciplinarity[J]. Int J Environ Res Public Health, 2022, 19(19): 12728. doi:10.3390/ijerph191912728. [8] Abdel-Razeq H, Mansour A. Challenges and opportunities in breast cancer care in low-resourced countries, Jordan as an example[J]. Cancers, 2024, 16(9): 1751. doi:10.3390/cancers16091751. [9] 艾宪程, 王斐, 周文重, 等. 山东省38所三甲医院乳腺多学科诊疗现状[J]. 山东大学学报(医学版), 2025, 63(1): 108-114. AI Xiancheng, WANG Fei, ZHOU Wenzhong, et al. Current status of breast multidisciplinary team in 38 tertiary hospitals in Shandong Province, China[J]. Journal of Shandong University(Health Sciences), 2025, 63(1):108-114. [10] Shinji O. Multidisciplinary care for patients with breast cancer[J]. Nihon Geka Gakkai Zasshi, 2017, 118(2): 173-178. [11] Capobianco AL, Gallucci G, Lapadula L, et al. Impact of the multidisciplinary cancer team on the diagnostic and therapeutic care pathway of early breast cancer patients and perception of team members: the experience of a cancer centre in Italy[J]. Cancer Invest, 2024, 42(1): 12-20. [12] Horlait M, Baes S, De Regge M, et al. Understanding the complexity, underlying processes, and influencing factors for optimal multidisciplinary teamwork in hospital-based cancer teams: a systematic integrative review[J]. Cancer Nurs, 2021, 44(6): 476-492. [13] Puschel K, León A, Arancibia V, et al. The interdisciplinary and psychosocial gap in cancer survivorship: a longitudinal study in a Latin American Cancer Center[J]. J Surg Oncol, 2021, 124(5): 876-885. [14] Cherny NI, Paluch-Shimon S, Berner-Wygoda Y. Palliative care: needs of advanced breast cancer patients[J]. Breast Cancer, 2018, 10: 231-243. doi:10.2147/BCTT.S160462. [15] Aly SH, Abulsoud AI, Moustafa YM, et al. Harnessing natural compounds to modulate miRNAs in breast cancer therapy[J]. Funct Integr Genomics, 2024, 24: 211. doi: 10.1007/s10142-024-01489-7. [16] Balcioglu O, Gates BL, Freeman DW, et al. Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation[J]. NPJ Breast Cancer, 2024, 10: 80. doi: 10.1038/s41523-024-00687-7. [17] Sinha AP, Jurrius P, van Schelt AS, et al. Tumor biomechanics quantified using MR elastography to predict response to neoadjuvant chemotherapy in individuals with breast cancer[J]. Radiol Imaging Cancer, 2025, 7: e240138. doi: 10.1148/rycan.240138. [18] Yu Y, Tan Y, Xie C, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer[J]. JAMA Network Open, 2020, 3: e2028086. doi: 10.1001/jamanetworkopen.2020.28086. [19] Zhu JY, He HL, Lin ZM, et al. Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis[J]. Front Oncol, 2022, 12: 951973. doi: 10.3389/fonc.2022.951973. [20] Moser EC, Narayan G. Improving breast cancer care coordination and symptom management by using AI driven predictive toolkits[J]. Breast, 2020, 50: 25-29. doi:10.1016/j.breast.2019.12.006. [21] Strach MC, Prasanna T, Kirova YM, et al. Optimise not compromise: the importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery[J]. Crit Rev Oncol Hematol, 2019, 134: 10-21. doi:10.1016/j.critrevonc.2018.11.007. [22] Wind A, Gonçalves FR, Marosi E, et al. Benchmarking cancer centers: from care pathways to integrated practice units[J]. J Natl Compr Canc Netw, 2018, 16(9): 1075-1083. [23] Redjdal A, Bouaud J, Gligorov J, et al. Using machine learning and deep learning methods to predict the complexity of breast cancer cases[J]. Stud Health Technol Inform, 2022, 294: 78-82. doi:10.3233/SHTI220400. [24] Vuksanovic D, Sanmugarajah J, Lunn D, et al. Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project[J]. Breast Cancer, 2021, 28(2): 289-297. [25] Monkkonen T, Traustadóttir Gá, Koledova Z. Unraveling the breast: advances in mammary biology and cancer methods[J]. J Mammary Gland Biol Neoplasia, 2020, 25(4): 233-236. [26] Zhang X, Zhang D, Yu PD, et al. Effects of continuous care combined with evidence-based nursing on mental status and quality of life and self-care ability in patients with liver from breast cancer: a single-center randomized controlled study[J]. Comput Math Methods Med, 2022: 3637792. doi:10.1155/2022/3637792. [27] Power K, Martone P, Khanna A, et al. The role of physiatry practice in a multidisciplinary breast tumor board: a descriptive study[J]. PM R, 2020, 12(5): 486-490. [28] Cheng VT, Heetun A, Robinson T, et al. The breast cancer trainees research collaborative group: a new multidisciplinary network to facilitate breast cancer research[J]. Clin Oncol, 2020, 32(1): 16-18. [29] 张舒妮,赵楠楠,李阳,等. 多模态影像组学列线图术前预测乳腺浸润性导管癌腋窝淋巴结转移的价值[J]. 磁共振成像, 2024, 15(4): 78-87. ZHANG Shuni, ZHAO Nannan, LI Yang, et al. Value of multimodal radiomics nomogram in predicting axillary lymph node metastasis in invasive ductal carcinoma of the breast before surgery[J]. Chin J Magn Reson Imaging, 2024, 15(4): 78-87. [30] Verhoeven D, Allemani C, Kaufman C, et al. New frontiers for fairer breast cancer care in a globalized world[J]. Eur J Breast Health, 2021, 17(2): 86-94. |
| [1] | 古春青,郭睿思,周勤勤,刘恒辉,巴婉玉,孙士玲,王冰,郑玉玲,吴宿慧. 基于网络药理学和动物实验探讨酸枣仁-远志药对治疗乳腺癌相关性失眠的作用机制[J]. 山东大学学报 (医学版), 2026, 64(1): 99-108. |
| [2] | 刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74. |
| [3] | 王雪梅,杨豪,宋洋,程世超,张婷婷,王艳春. 抗糖尿病药物与女性恶性肿瘤的因果关联:一项两样本孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(6): 67-77. |
| [4] | 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16. |
| [5] | 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24. |
| [6] | 王敏, 李习平, 檀军, 邱梅, 侯泽宇, 田莹, 罗鸿莹, 范超文, 齐玲, 俞琦, 谢薇. 慢病毒载体介导Gag-Caspase-8诱导三阴性乳腺癌原代细胞凋亡及S期阻滞[J]. 山东大学学报 (医学版), 2025, 63(1): 25-34. |
| [7] | 张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42. |
| [8] | 宋雅雯,郭联涛,孔德光,孙圣荣. VTCN1导致HR+乳腺癌预后不良及内分泌治疗耐药[J]. 山东大学学报 (医学版), 2025, 63(1): 43-59. |
| [9] | 刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72. |
| [10] | 孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80. |
| [11] | 李永,崔书君,杨飞,张凡,殷晓霞. 基于增强MRI的亚区域影像组学模型可预测乳腺癌患者新辅助化疗后的病理完全反应[J]. 山东大学学报 (医学版), 2025, 63(1): 81-89. |
| [12] | 袁宗怀,潘广晔,迟曰梅,安传国,张永刚. 孟德尔随机化分析低级别浆液性卵巢癌与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2025, 63(1): 99-107. |
| [13] | 艾宪程,王斐,周文重,于理想,周飞,相玉娟,李亮,余之刚. 山东省38所三甲医院乳腺多学科诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(1): 108-114. |
| [14] | 刘向荣,张新胜,杨荩冉,杨雪艳,刘钊,刘英华. ω-6/ω-3多不饱和脂肪酸比值对不同肿瘤发病风险的系统综述和Meta分析[J]. 山东大学学报 (医学版), 2024, 62(8): 34-48. |
| [15] | 张娜娜,赵一鸣,刘新敏. 基于两样本孟德尔随机化探索子宫肌瘤与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2023, 61(8): 86-93. |
|
||